Medtronic (MDT) EVP reports 1,371-share tax withholding

Rhea-AI Filing Summary

Medtronic executive insider reported a routine tax-related share withholding. On 12/15/2025, the company’s EVP, President MedSurg and Americas had 1,371 ordinary shares withheld at $99.87 per share to cover taxes when previously reported restricted stock units vested due to retirement eligibility. After this transaction, the executive beneficially owns 50,818 Medtronic shares, including 250 shares acquired through dividend reinvestment since the last report, all held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Marinaro Michael

(Last) (First) (Middle)

710 MEDTRONIC PARKWAY

(Street)

MINNEAPOLIS MN 55432

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Pres MedSurg and Americas

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	12/15/2025		F		1,371(1)	D	$99.87	50,818(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to reporting person's retirement eligibility.

2. Includes 250 shares acquired through dividend reinvestment since the last report filed by the reporting person.

Remarks:

	/s/ Patricia Walesiewicz, attorney-in-fact	12/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider stock transaction did Medtronic (MDT) report on 12/15/2025?

Medtronic reported that 1,371 ordinary shares were withheld for taxes on 12/15/2025 at $99.87 per share in connection with the vesting of restricted stock units.

Who is the Medtronic (MDT) insider involved in this transaction and what is their role?

The reporting person is a Medtronic officer, serving as EVP, President MedSurg and Americas, and filed as a single reporting person.

How many Medtronic (MDT) shares does the executive own after the reported transaction?

Following the tax withholding transaction, the executive beneficially owns 50,818 Medtronic shares, held in a direct ownership capacity.

Was this Medtronic (MDT) insider transaction an open-market sale?

No. The 1,371 shares represent shares withheld for payment of taxes upon the vesting of previously reported restricted stock units, rather than an open-market sale.

How many Medtronic (MDT) shares were acquired through dividend reinvestment?

The holding total includes 250 shares acquired through dividend reinvestment since the last report filed by the reporting person.

What type of Medtronic (MDT) security was involved in the reported transaction?

The transaction involved ordinary shares of Medtronic, tied to the vesting of restricted stock units previously reported on Table I.